Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Option Care Health ( (OPCH) ) has provided an update.
Option Care Health reported mixed financial results for the first quarter ended March 31, 2026, with net revenue rising 1.3% year over year to $1.35 billion, but GAAP net income slipping 3.0% to $45.3 million and adjusted EBITDA falling 6.3% to $104.8 million. While GAAP diluted EPS improved 3.6% to $0.29 and adjusted EPS held flat at $0.40, the company used $12.1 million in operating cash, repurchased $17.5 million of stock, expanded its revolving credit facility from $400 million to $850 million, and updated its 2026 guidance to reflect expectations for full-year revenue of $5.675 billion to $5.775 billion, adjusted EPS of $1.82 to $1.92, adjusted EBITDA of $480 million to $505 million, and at least $320 million in operating cash flow, as management signals decisive actions to re-accelerate growth despite slowing momentum.
The most recent analyst rating on (OPCH) stock is a Buy with a $28.33 price target. To see the full list of analyst forecasts on Option Care Health stock, see the OPCH Stock Forecast page.
Spark’s Take on OPCH Stock
According to Spark, TipRanks’ AI Analyst, OPCH is a Neutral.
The score is driven primarily by solid fundamentals and a constructive earnings outlook with reaffirmed 2026 targets, partly offset by recent margin/cash-flow cooling and leverage considerations. Technicals are the main drag, with a pronounced downtrend despite oversold readings; valuation is broadly neutral with no dividend support.
To see Spark’s full report on OPCH stock, click here.
More about Option Care Health
Option Care Health, Inc., listed on Nasdaq as OPCH, is the largest independent provider of home and alternate site infusion services in the United States. With more than 8,000 employees, including over 5,000 clinicians, it delivers infusion therapies for patients with acute and chronic conditions across all 50 states, leveraging national scale and clinical expertise to reimagine the infusion care experience.
Average Trading Volume: 1,805,831
Technical Sentiment Signal: Sell
Current Market Cap: $4.22B
See more data about OPCH stock on TipRanks’ Stock Analysis page.